Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.
Chiara TaniChiara CardelliMargherita ZenLuca MoroniMatteo PigaFulvia CeccarelliSerena FasanoGinevra De MarchiLaura ColadonatoGiacomo EmmiMariele GattoFrancesca TrentinGiuseppe A RamirezElisabetta ChessaGabriele GallinaLicia PicciarielloMartina PatroneMaria L UrbanEdoardo BiancalanaLuca QuartuccioFrancesco CicciaFabrizio ContiAlberto CauliLorenzo DagnaAndrea DoriaMarta MoscaPublished in: The Journal of rheumatology (2024)
This study provides real-world experience on the use of ANI in patients with refractory SLE, confirming its rapid effectiveness and an overall acceptable safety profile.